ORKA – oruka therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Oruka Therapeutics, Inc. (NASDAQ: ORKA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $45.00 price target on the stock.
Oruka Therapeutics, Inc. (NASDAQ: ORKA) was upgraded by analysts at Wolfe Research to a "strong-buy" rating.
Oruka Therapeutics, Inc. (NASDAQ: ORKA) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $20.00 price target on the stock.
Oruka Therapeutics, Inc. (NASDAQ: ORKA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $45.00 price target on the stock.
Oruka Therapeutics Announces First Participants Dosed in Phase 1 Trial of ORKA-001, its Novel Half-life Extended Anti-IL-23p19 Antibody [Yahoo! Finance]
Form 8-K Oruka Therapeutics, Inc. For: Feb 04
Form 4 Oruka Therapeutics, Inc. For: Jan 22 Filed by: Agarwal Arjun
Form 4 Oruka Therapeutics, Inc. For: Jan 22 Filed by: Goncalves Joana
Form 4 Oruka Therapeutics, Inc. For: Jan 22 Filed by: Quinlan Paul T
Form 4 Oruka Therapeutics, Inc. For: Jan 22 Filed by: Klein Lawrence Otto
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.